Skip to main content
. 2021 Mar 12;11:11–24. doi: 10.2147/BLCTT.S245191

Table 3.

Currently Open Clinical Trials Investigating BCL2 Family Inhibitors

Study Additional Agents Phase Patient Population
Lines of Therapy Cytogenetics
Venetoclax NCT02899052 Carfilzomib/dex 2 ≥1 t(11;14)
NCT03539744 Venetoclax/dex vs pomalidomide/dex 3 ≥2 t(11;14)
NCT03314181 Daratumumab/dex ± bortezomib 1/2
AZD5991 NCT03218683 1 ≥2
AMG176 NCT02675452 1 ≥2
AMG397 NCT03465540 1
S64315 NCT02992483 1 ≥1
ABBV467 NCT04178902 1 ≥3

Abbreviation: Dex, dexamethasone.